$DOC

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.

Healthpeak Properties (DOC) is a U.S. healthcare REIT with a $14.9B market cap. The stock rose 31.8% over the past year and nearly 41% in 2026. After Q2 2026 results on Aug. 4, revenue was $771.6M and adjusted FFO was $0.46, both above estimates. Full-year FFO guidance is $1.73 to $1.77. Analysts rate DOC a “Moderate Buy,” with Barclays holding a $23 target.

HEALTHPEAK PROPERTIES, INC. (DOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 ex99306302026.htm EX-99.3 Document Exhibit 99.3 Discussion and Reconciliation of Healthpeak's Non-GAAP Financial Measures June 30, 2026 (Unaudited) Definitions Adjusted Fixed Charge Coverage Fixed Charge Coverage Adjusted EBITDAre divided by Fixed Charges. Adjusted Fixe

Brookfield Asset Management and its affiliates formed a joint venture with Healthpeak Properties to obtain a 49% interest in Healthpeak’s 86 outpatient medical buildings nationwide, valued at about $2.1B. The portfolio totals about 5.6M sq ft across 11 states and is 95% leased, per the announcement. Healthpeak keeps 51% control and received about $1B in gross proceeds.

Brookfield Asset Management will form a U.S. outpatient medical buildings joint venture with Healthpeak Properties. Healthpeak will contribute 86 properties valued at about US$2.1 billion. Brookfield and affiliates will hold 49% and receive about US$1.03 billion in gross proceeds, while Healthpeak holds 51% and manages. The portfolio is 95% leased across 11 states.

Healthpeak Properties (DOC) is set to report fiscal Q2 2026 results after the close Aug. 4. Analysts expect adjusted FFO of $0.44 per share, down from $0.46 a year earlier. For fiscal 2026, consensus calls for adjusted FFO of $1.75 per share. The stock is rated “Moderate Buy” with a $21.71 average target.

Scotiabank raised its price target for Healthpeak Properties (NYSE:DOC) from $19.00 to $21.00 and kept a “sector perform” rating, implying about 4.19% upside from the prior close, according to the note reported by Benzinga. The article also cites other analyst target changes and notes DOC traded at $20.16 on Wednesday.

Invesco’s SPHD ETF targets the S&P 500’s highest-dividend stocks, then selects the 50 lowest realized-volatility names and weights by yield. Over five years, SPHD returned 36% total (~6% annualized) versus SPY’s 92% with dividends reinvested. The article cites SPHD’s 4.5% monthly yield and higher 0.30% fee, arguing alternatives like Schwab’s SCHD (0.06% fee, 53% five-year return) have outperformed.

Welltower Inc. (US95040Q1040) is gaining renewed investor attention as its stock trades near record levels at $216.22 on May 20, 2026. The REIT specializes in senior housing and health-care properties, offering exposure to the aging population demographic in the US and Canada. Its business model, focused on lease income and property operations, makes its performance sensitive to occupancy rates, rent growth, and interest-rate expectations.

National Healthcare Properties (NHP) reported strong Q1 2026 results with normalized FFO doubling year-over-year to $0.26 per share, following its April 2026 IPO. The company is strategically shifting focus to senior housing, planning significant acquisitions and divestitures of outpatient medical facilities. NHP's stock saw a 2.05% premarket increase, reflecting investor confidence in its strategic direction and operational performance.